Abrdn Life Sciences Investors (HQL)

NYSE: HQL · Real-Time Price · USD

17.17

+0.01 (0.06%)

At close: Feb 3, 2026, 4:00 PM EST

17.25

+0.08 (0.47%)

After-hours: Feb 3, 2026, 6:25 PM EST

HQL Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 3, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Capitalization	508	448	412	343	505	413
Market Cap Growth	-	8.58%	20.08%	-31.99%	22.27%	20.21%
Enterprise Value	508	448	422	352	505	413
Last Close Price	17.17	15.05	12.79	9.38	13.07	10.17
PE Ratio	5.94	5.23	4.84	-	7.83	3.36
PS Ratio	262.18	231.02	103.63	113.77	220.89	121.78
PB Ratio	0.99	0.87	0.90	0.86	0.97	0.85
P/TBV Ratio	0.99	0.87	0.90	0.86	0.97	0.85
P/OCF Ratio	16.03	14.12	-	-	-	-
EV/Sales Ratio	262.14	231.02	105.98	116.55	220.89	121.78
Debt / Equity Ratio	-	-	-	0.03	0.02	0
Asset Turnover	0.00	0.00	-	0.01	0.00	0.01
Quick Ratio	0.71	0.71	0.27	0.04	0.01	0.28
Current Ratio	0.73	0.73	0.32	0.70	0.80	8.88
Return on Equity (ROE)	17.59%	17.59%	-	-22.71%	12.82%	28.38%
Return on Assets (ROA)	-0.43%	-0.43%	-	-0.39%	-0.51%	-0.30%
Return on Capital Employed (ROCE)	-0.70%	-0.70%	-0.40%	-0.80%	-0.80%	-0.40%
Earnings Yield	16.84%	19.11%	20.68%	-30.45%	12.78%	29.79%
Dividend Yield	10.60%	12.09%	12.97%	15.67%	12.78%	14.45%
Payout Ratio	62.94%	36.96%	-	-	-	-
Buyback Yield / Dilution	-5.48%	-5.48%	-9.28%	-4.10%	-3.29%	-3.03%
Total Shareholder Return	5.12%	6.62%	3.70%	11.57%	9.49%	11.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q